Sign in
8-K

Current Report

Cogent Biosciences, Inc. Filed Acc 0001193125-20-010115

Agreement ended

  • Item 1.02 Termination of a material definitive agreement

From the SEC's structured data for this filing

Loading d849604d8k.htm…